Picard Medical (PMI) Net Income towards Common Stockholders (2024 - 2026)

Picard Medical's Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$7.6 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 20.11% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$29.9 million (down 8.71% YoY) and the FY2025 annual result came in at -$27.0 million, down 13.75% from the prior year.
• Net Income towards Common Stockholders was -$7.6 million for Q1 2026 at Picard Medical, down from -$4.3 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at -$4.3 million in Q4 2025 and bottomed at -$10.4 million in Q3 2025.
• A 3-year average of -$7.2 million and a median of -$7.2 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Peak annual rise in Net Income towards Common Stockholders reached 54.87% in 2025, while the deepest fall reached 59.29% in 2025.
• Picard Medical's Net Income towards Common Stockholders stood at -$9.5 million in 2024, then jumped by 54.87% to -$4.3 million in 2025, then plunged by 77.49% to -$7.6 million in 2026.
• Business Quant data shows PMI's Net Income towards Common Stockholders at -$7.6 million in Q1 2026, -$4.3 million in Q4 2025, and -$10.4 million in Q3 2025.